Results 41 to 50 of about 24,104,894 (214)
Longitudinal analysis of P. malariae and the effect of co-infection.
The prevalence of (A) P. malariae asexual parasites, and (B) P. malariae gametocytes. The prevalence of all P. malariae infections is shown in green, and the prevalence of P. malariae and P. falciparum co-infection is shown in red. The grey shaded region
Ingrid Felger (92160) +8 more
core +1 more source
Effect of transmission setting and mixed species infections on clinical measures of malaria in Malawi [PDF]
<p>Background: In malaria endemic regions people are commonly infected with multiple species of malaria parasites but the clinical impact of these Plasmodium co-infections is unclear.
Alex McConnachie +23 more
core +2 more sources
Plasmodium malariae, a neglected human malaria parasite, contributes up to 10% of malaria infections in sub-Saharan Africa (sSA). Though P. malariae infection is considered clinically benign, it presents mostly as coinfections with the dominant P ...
Eniyou C. Oriero +11 more
doaj +1 more source
Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon [PDF]
Background: The recommendation of artemisinin combination therapy (ACT) as first-line treatment for uncomplicated falciparum malaria is supported by a plethora of high quality clinical trials.
Mesküre Capan +43 more
core +1 more source
Background Plasmodium malariae is characterized by its long asymptomatic persistence in the human host. The epidemiology of P. malariae is incompletely understood and is hampered by the limited knowledge of genetic polymorphisms.
Naowarat Saralamba +10 more
doaj +1 more source
A 20-year longitudinal study of Plasmodium ovale and Plasmodium malariae prevalence and morbidity in a West African population. [PDF]
BACKGROUND: Plasmodium ovale and Plasmodium malariae have long been reported to be widely distributed in tropical Africa and in other major malaria-endemic areas of the world. However, little is known about the burden caused by these two malaria species.
Clémentine Roucher +4 more
doaj +1 more source
Mefloquine in the Prophylaxis ofP. FalciparumMalaria [PDF]
Background: The objectives of this study were (1) to compare the efficacy of Lariam (mefloquine) with that of Fansimef (mefloquine, sulfadoxine, and pyrimethamine), Fansidar (sulfadoxine and pyrimethamine), chloroquine, and placebo in suppressing asexual parasitemia in semi-immune persons living in an area endemic for Plasmodium falciparum malaria; and
, Sossouhounto +5 more
openaire +2 more sources
Spectrum of Clinical Manifestations in Patients Diagnosed of Malaria and to Compare the Severity of P. Vivax and P. Falciparum Malaria [PDF]
Aim: The aim of our study was to find out the spectrum of clinical manifestations, infecting species, age distribution and mortality in admitted patients of malaria in our hospital and to compare the clinical profile with severity of P.vivax and P. falciparum malaria.
Kumari Preeti Ranjana +2 more
openaire +1 more source
Genetic diversity of P. malariae in sub-Saharan Africa
This study characterized P. malariae isolates from malaria cases across seven countries in sub-Saharan Africa, using targeted amplicon sequencing to explore polymorphisms in orthologues of P.
MRC Unit The Gambia at LSHTM
core +3 more sources
Background Clinical presentations of malaria in Ghana are primarily caused by infections containing microscopic densities of Plasmodium falciparum, with a minor contribution from Plasmodium malariae and Plasmodium ovale.
Linda E. Amoah +10 more
doaj +1 more source

